Literature DB >> 12871266

Von Willebrand factor, platelets and endothelial cell interactions.

Z M Ruggeri1.   

Abstract

The adhesive protein von Willebrand factor (VWF) contributes to platelet function by mediating the initiation and progression of thrombus formation at sites of vascular injury. In recent years there has been considerable progress in explaining the biological properties of VWF, including the structural and functional characteristics of specific domains. The mechanism of interaction between the VWF A1 domain and glycoprotein Ibalpha has been elucidated in detail, bringing us closer to understanding how this adhesive bond can oppose the fluid dynamic effects of rapidly flowing blood contributing to platelet adhesion and activation. Moreover, novel findings have been obtained on the link between regulation of VWF multimer size and microvascular thrombosis. This progress in basic research has provided critical information to define with greater precision the role of VWF in vascular biology and pathology, including its possible involvement in the onset of atherosclerosis and its acute thrombotic complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871266     DOI: 10.1046/j.1538-7836.2003.00260.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  92 in total

Review 1.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

2.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture.

Authors:  Shogo Kasuda; Hideto Matsui; Shiro Ono; Yasunori Matsunari; Kenji Nishio; Midori Shima; Katsuhiko Hatake; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

3.  von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

Authors:  Anil K Chauhan; Janka Kisucka; Colin B Lamb; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

4.  Shear stress induced release of von Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion.

Authors:  Noëlia Gomes; Chantal Legrand; Françoise Fauvel-Lafève
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

6.  Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivity.

Authors:  Frédéric Frank Weller
Journal:  J Math Biol       Date:  2008-02-15       Impact factor: 2.259

7.  Translational medicine advances in von Willebrand disease.

Authors:  D Lillicrap
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

8.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

9.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers.

Authors:  S W Schneider; S Nuschele; A Wixforth; C Gorzelanny; A Alexander-Katz; R R Netz; M F Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

10.  Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions.

Authors:  Yasunori Matsunari; Mitsuhiko Sugimoto; Masaaki Doi; Hideto Matsui; Masahiko Kawaguchi
Journal:  Int J Hematol       Date:  2016-08-25       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.